5-Amino-1MQ

Research ChemicalModerate Research

Also known as: 5-Amino 1-Methylquinolinium · NNMT Inhibitor

A small molecule NNMT inhibitor that boosts cellular energy metabolism, promotes fat loss, and may reverse diet-induced obesity by restoring NAD+ levels.

Overview

5-Amino-1MQ is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that plays a central role in cellular energy metabolism. NNMT consumes methyl groups from SAM (S-adenosylmethionine) and degrades NAD+ precursors, effectively reducing the cell's energy currency. When NNMT is overexpressed — as commonly seen in obesity and metabolic dysfunction — it creates a metabolic bottleneck that promotes fat storage and reduces energy expenditure. By inhibiting NNMT, 5-Amino-1MQ restores NAD+ levels, increases SAM availability for methylation reactions, activates the sirtuin pathway, and shifts cellular metabolism toward fat oxidation.

In preclinical studies, 5-Amino-1MQ has demonstrated significant reductions in body weight and fat mass without affecting food intake, suggesting it works by increasing metabolic rate rather than suppressing appetite. Available in both injectable and oral formulations, it is increasingly popular in health optimization protocols for body composition improvement.

Mechanism of Action

Inhibits nicotinamide N-methyltransferase (NNMT), preventing the enzyme from consuming SAM and degrading NAD+ precursors. This restores intracellular NAD+ pools, activates sirtuins (SIRT1/SIRT3), enhances mitochondrial function, increases fatty acid oxidation, and shifts adipocyte metabolism from lipogenesis to lipolysis.

Key Benefits

Promotes fat loss without appetite suppression
Increases cellular NAD+ levels
Enhances metabolic rate and energy expenditure
May reduce cholesterol levels
Supports mitochondrial function
Potential anti-aging effects via sirtuin activation

Potential Side Effects

Injection site reactions
Mild GI discomfort (oral)
Headache (uncommon)
Potential interaction with methylation pathways

Common Stacks

This peptide is commonly combined with the following compounds for synergistic effects:

NAD+ / NMNL-CarnitineAOD-9604Semaglutide

Known Interactions

The following interactions have been documented for 5-Amino-1MQ. Always consult a healthcare professional before combining compounds.

Synergistic (1)

NAD+ / NMNSynergistic

5-Amino-1MQ inhibits NNMT (which degrades NAD+) while NMN provides NAD+ precursors. Together they boost cellular NAD+ levels from both sides.

View all compound interactions

Scientific References

Quick Reference

Typical Dose

0.5mg-2mg (inj) or 50mg-150mg (oral)

Frequency

1-2x daily (inj AM/PM) or 2-3x daily (oral)

Route

Subcutaneous injection or oral capsule

Half-Life

~4-6 hours

Cycle Length

8-16 weeks, followed by 4 weeks recovery

FDA Status

Research compound — not FDA approved. Currently in preclinical development.

Need to calculate dosing?

Use our reconstitution calculator to determine exact syringe measurements.

Open Calculator

This information is for educational purposes only. Consult a qualified healthcare professional before using any peptide. Dosing information reflects commonly reported protocols and may not be appropriate for everyone.

Related Peptides in Supplements & Nutraceuticals